$VRNA Verona Pharma plc Insider Trading
Get free email notifications about insider trading in Verona Pharma plc.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Verona Pharma plc. Insider overview, share value development, latest insider transactions and email notifications about new events in Verona Pharma plc for free.
CIK Number: 0001657312
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Trading Symbol: VRNA
Company Address: 3 MORE LONDON RIVERSIDE LONDON SE1 2RE
Phone number: 011-44-0-2032834
Verona Pharma plc Latest Insider Transactions
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
May 05 2021 | VRNA | Verona Pharma plc | Ullman Anders | Director | Sell | S | 0.84 | 12,056 | 10,123 | 334,856 | 346.9 K to 334.9 K (-3.48 %) |
May 05 2021 | VRNA | Verona Pharma plc | Deschamps Lisa | Director | Sell | S | 0.84 | 10,680 | 8,968 | 105,320 | 116 K to 105.3 K (-9.21 %) |
May 05 2021 | VRNA | Verona Pharma plc | Cunningham Kenneth | Director | Sell | S | 0.84 | 13,112 | 11,010 | 66,584 | 79.7 K to 66.6 K (-16.45 %) |
May 05 2021 | VRNA | Verona Pharma plc | Sinha Vikas | Director | Sell | S | 0.84 | 10,016 | 8,410 | 74,440 | 84.5 K to 74.4 K (-11.86 %) |
May 05 2021 | VRNA | Verona Pharma plc | EBSWORTH DAVID R | Director | Sell | S | 0.84 | 11,184 | 9,391 | 684,643 | 695.8 K to 684.6 K (-1.61 %) |
May 05 2021 | VRNA | Verona Pharma plc | Edwards Martin | Director | Sell | S | 0.84 | 12,024 | 10,097 | 111,064 | 123.1 K to 111.1 K (-9.77 %) |
May 05 2021 | VRNA | Verona Pharma plc | SHAH MAHENDRA | Director | Sell | S | 0.84 | 10,680 | 8,968 | 73,080 | 83.8 K to 73.1 K (-12.75 %) |
May 05 2021 | VRNA | Verona Pharma plc | ZACCARDELLI DAVID | President and CEO | Sell | S | 0.81 | 52,056 | 41,926 | 17,859,160 | 17.9 M to 17.9 M (-0.29 %) |
May 05 2021 | VRNA | Verona Pharma plc | ZACCARDELLI DAVID | President and CEO | Payment of Exercise | F | 0.89 | 2,139,632 | 1,898,923 | 17,911,216 | 20.1 M to 17.9 M (-10.67 %) |
Mar 03 2021 | VRNA | Verona Pharma plc | Hahn Mark W | Chief Financial Off ... | Sell | S | 1.14 | 26,728 | 30,571 | 19,054,504 | 19.1 M to 19.1 M (-0.14 %) |
Mar 03 2021 | VRNA | Verona Pharma plc | ZACCARDELLI DAVID | President and CEO | Sell | S | 1.14 | 43,392 | 49,627 | 20,050,848 | 20.1 M to 20.1 M (-0.22 %) |
Mar 03 2021 | VRNA | Verona Pharma plc | Deschamps Lisa | Director | Grant | A | 0.00 | 116,000 | 0 | 116,000 | 0 to 116 K |
Feb 03 2021 | VRNA | Verona Pharma plc | Ullman Anders | Director | Sell | S | 0.99 | 10,800 | 10,733 | 346,912 | 357.7 K to 346.9 K (-3.02 %) |
Feb 03 2021 | VRNA | Verona Pharma plc | Sinha Vikas | Director | Sell | S | 0.99 | 10,224 | 10,161 | 84,456 | 94.7 K to 84.5 K (-10.80 %) |
Feb 03 2021 | VRNA | Verona Pharma plc | SHAH MAHENDRA | Director | Sell | S | 0.99 | 10,800 | 10,733 | 83,760 | 94.6 K to 83.8 K (-11.42 %) |